Concordia
NHS faced with 5,700% increase in drug price, finds CMA
November 21, 2017Manufacturing and Production, Medical Communications CMA, Concordia, biotech, drugs, pharma, pharmaceutical
The Competition and Markets Authority (CMA) has pulled up Concordia as, provisionally, being found to have raised the price of …
CMA accuses Concordia and Actavis of illegal agreement to maintain high prices
March 3, 2017Medical Communications, Sales and Marketing Actavis UK, CMA, Concordia, competition and markets authority
The Competition and Markets Authority (CMA) has alleged that Concordia and Actavis UK entered into a clandestine agreement to maintain …
Concordia founder resigns and will step down once replacement found
October 25, 2016Manufacturing and Production CEO, Concordia, Mark Thompson, Valeant
Concordia International Corp., the Ontario-based company, has announced that its founder, Chairman and Chief Executive Officer, Mark Thompson, will leave …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
September 25, 2026
One in three UK women with migraine say symptoms taken less seriously
September 24, 2026
Report highlights scope to expand day surgery
September 23, 2026
Sygnature formalises drug discovery collaboration with X-Chem
September 22, 2026
Codis appoints Steven Facer as chief commercial officer
September 21, 2026
